Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2022-04-07 21:17 Tx date 2022-03-31 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Mullally, William Hogan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$157,500
+450,000 vol $0.35 each |
450,000 | |
Filed 2022-03-31 10:03 Tx date 2022-03-30 |
$ROZP
Rozdil Capital Corporation |
Mullally, William Hogan
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,500
+125,000 vol $0.10 each |
875,000 | |
Filed 2022-03-31 09:59 Tx date 2022-03-30 |
$ROZP
Rozdil Capital Corporation |
Mullally, William Hogan
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,500
-125,000 vol $0.10 each |
0 | |
Filed 2019-07-18 12:12 Tx date 2019-05-27 |
$ROZP
Rozdil Capital Corporation |
Mullally, William Hogan
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
125,000 | ||
Filed 2019-07-17 18:03 Tx date 2019-05-27 |
$ROZP
Rozdil Capital Corporation |
Mullally, William Hogan
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-07-17 18:03 Tx date 2019-05-27 |
$ROZP
Rozdil Capital Corporation |
Mullally, William Hogan
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
125,000 | ||
Filed 2019-06-11 10:50 Tx date 2019-05-27 |
$
Rozdil Capital Corporation |
Mullally, William Hogan
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
750,000 |